Search Prime Grants

W81XWH2110875

Project Grant

Overview

Grant Description
Phase 1 clinical trial for therapeutic intervention particles (TIPS).
Awardee
J.David Gladstone Institutes
Funding Goals
JOINT WARFIGHTER MEDICAL RESEARCH PROGRAM
Grant Program (CFDA)
12.420 - Military Medical Research and Development
Awarding / Funding Agency
Defense Health Agency (DHA) [DoD]
Place of Performance
San Francisco, California 941582261 United States
Geographic Scope
Single Zip Code
Related Opportunity
W81XWH20JWMRP
Analysis Notes
Amendment Since initial award the End Date has been extended from 09/29/24 to 09/29/26 and the total obligations have decreased 100% from $4,499,999 to $0.
J.David Gladstone Institutes was awarded TIPS Phase 1 Trial: Safety & Efficacy Project Grant W81XWH2110875 from Defense Health Agency in September 2021 with work to be completed primarily in San Francisco California United States. The grant has a duration of 5 years and was awarded through assistance program 12.420 Military Medical Research and Development.

Status
(Ongoing)

Last Modified 5/21/25

Period of Performance
9/30/21
Start Date
9/29/26
End Date
78.0% Complete

Funding Split
$0.0
Federal Obligation
$0.0
Non-Federal Obligation
$0.0
Total Obligated
100% Federal Funding
0% Non-Federal Funding

Transaction History

Modifications to W81XWH2110875

Additional Detail

Award ID FAIN
W81XWH2110875
SAI Number
None
Award ID URI
None
Awardee Classifications
Nonprofit With 501(c)(3) IRS Status (Other Than An Institution Of Higher Education)
Awarding Office
HT9425 ARMY MED RES ACQ ACTIVITY
Funding Office
HT0989 CONG DIR MED RES PRGM / CDMRP - MM
Awardee UEI
KH6NJ6ND8737
Awardee CAGE
3HSQ5
Performance District
CA-11
Senators
Dianne Feinstein
Alejandro Padilla
Modified: 5/21/25